Bladder Cancer Coverage from Every Angle
Advertisement
Advertisement

Thomas W. Flaig, MD, on Choosing Among Many New Bladder Cancer Treatment Options

Posted: Tuesday, April 19, 2022

Thomas W. Flaig, MD, of the University of Colorado Cancer Center, discusses what clinicians need to know when choosing among newer agents: how they differ from earlier standard-of-care regimens, whether they represent improvements, how well they are tolerated, and their durability.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.